Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/12/2026 | Q4 | $958.3M | -- | -- | $0.65 | -- |
| 11/03/2025 | Q3 | $847M | $860.5M | -$0.41 | $0.32 | -$0.74 |
| 08/04/2025 | Q2 | $810.2M | $797.4M | $0.05 | $0.42 | -$0.37 |
| 05/07/2025 | Q1 | $772.5M | $801.4M | $0.11 | $0.44 | -$0.33 |
| 02/13/2025 | Q4 | $965.6M | $979.6M | $0.09 | $0.74 | -$0.65 |
| 11/05/2024 | Q3 | $866.1M | $864.4M | $0.27 | $0.60 | -$0.33 |
| 08/06/2024 | Q2 | $797.8M | $800.7M | $0.05 | $0.51 | -$0.46 |
| 05/02/2024 | Q1 | $729M | $721.7M | $0.35 | $0.46 | -$0.11 |
| 02/13/2024 | Q4 | $804.7M | $854.5M | $1.41 | $0.66 | $0.75 |
| 11/02/2023 | Q3 | -- | -- | $0.60 | $0.63 | -$0.03 |
| 08/03/2023 | Q2 | -- | -- | $0.39 | $0.49 | -$0.10 |
| 05/04/2023 | Q1 | -- | -- | $0.52 | $0.55 | -$0.03 |
| 02/09/2023 | Q4 | -- | -- | $0.66 | $0.72 | -$0.06 |
| 11/03/2022 | Q3 | -- | -- | $0.59 | $0.56 | $0.03 |
| 08/03/2022 | Q2 | -- | -- | $0.33 | $0.45 | -$0.12 |
| 05/04/2022 | Q1 | -- | -- | $0.41 | $0.42 | -$0.01 |
| 02/11/2022 | Q4 | -- | -- | $0.50 | $0.58 | -$0.08 |
| 11/01/2021 | Q3 | -- | -- | $0.57 | $0.44 | $0.13 |
| 08/02/2021 | Q2 | -- | -- | $0.38 | $0.38 | -$0.00 |
| 05/05/2021 | Q1 | -- | -- | $0.37 | $0.33 | $0.04 |
| 02/16/2021 | Q4 | -- | -- | $0.45 | $0.56 | -$0.11 |
| 11/02/2020 | Q3 | -- | -- | $0.35 | $0.31 | $0.04 |
| 08/03/2020 | Q2 | -- | -- | $0.16 | $0.05 | $0.11 |
| 05/06/2020 | Q1 | -- | -- | $0.07 | $0.22 | -$0.15 |
| 02/12/2020 | Q4 | -- | -- | $0.44 | $0.59 | -$0.15 |
| 10/31/2019 | Q3 | -- | -- | $0.39 | $0.38 | $0.01 |
| 08/01/2019 | Q2 | -- | -- | -- | $0.30 | -- |
| 05/02/2019 | Q1 | -- | -- | -- | $0.24 | -- |
| 02/11/2019 | Q4 | -- | -- | -- | $0.54 | -- |
| 11/01/2018 | Q3 | -- | -- | -- | $0.30 | -- |
| 08/02/2018 | Q2 | -- | -- | -- | -- | -- |
| 05/03/2018 | Q1 | -- | -- | -- | -- | -- |
| 02/08/2018 | Q4 | -- | -- | -- | -- | -- |
| 11/02/2017 | Q3 | -- | -- | -- | -- | -- |
| 08/03/2017 | Q2 | -- | -- | -- | -- | -- |
| 05/03/2017 | Q1 | -- | -- | -- | -- | -- |
| 02/13/2017 | Q4 | -- | -- | -- | -- | -- |
| 11/02/2016 | Q3 | -- | -- | -- | -- | -- |
| 08/02/2016 | Q2 | -- | -- | -- | -- | -- |
| 05/04/2016 | Q1 | -- | -- | -- | -- | -- |
| 02/10/2016 | Q4 | -- | -- | -- | -- | -- |
Bruker Corp. reported $860.5M worth of top line sales in its most recent quarter.
Bruker Corp. announced earnings per share of -$0.41 which represents a miss of analyst forecast a $0.32 per share.
Bruker Corp. reported $399.6M that represents $2.63 per share over the last quarter.
Bruker Corp.'s earnings are forecast to grow from $0.76 per share to $2.39 per share next year representing an increase of 148.08%.
Bruker Corp.'s next earnings date is February 12, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.